Metoprolol Succinate Tablet, Extended Release
Product Images NDC 68071-2651

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 68071-2651). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2651 1)

Pdp (68071 2651 1)
The label for metoprolol succinate 100 mg extended-release tablets from NuCare Pharmaceuticals, Inc. It shows the NDC 68071-2651-1 and indicates a package of 100 tablets. The label states each film-coated tablet contains metoprolol succinate equivalent to metoprolol tartrate 100 mg. It includes storage instructions and a warning to keep out of reach of children. Manufacturer details include Cadila Healthcare Ltd., Ahmedabad, India.*
FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 01)

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 01)
Chemical structure of metoprolol succinate, showing the molecular components that include a substituted aromatic ring with side chains, and the succinate moiety.*
FDA Label Image

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)

Figure (Fe222a69 B261 4e41 83ab Af76ee17812d 02)
A forest plot chart titled 'Results for Subgroups in MERIT-HF' showing relative risk and 95% confidence intervals for metoprolol succinate versus placebo. It presents three outcomes: total mortality, total mortality or all-cause hospitalization, and total mortality or hospitalization for heart failure. Subgroups include geographic region, NYHA class, ejection fraction, ischemic etiology, sex, race, MI history, diabetes status, hypertension history, and heart rate. The chart shows risk estimates favoring metoprolol succinate or placebo for each subgroup.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.